Luminor Medical Technologies Inc. (LMT.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2019 | 09-2019 | 06-2019 | 03-2019 | 12-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,514,000 | 2,539,000 | 1,167,000 | 991,000 | 772,000 |
| Receivables | 11,431,000 | 13,388,000 | 12,934,000 | 13,330,000 | 11,916,000 |
| Inventories | 3,619,000 | 3,474,000 | 3,599,000 | 3,285,000 | 2,997,000 |
| Other current assets | 531,000 | 402,000 | 400,000 | 425,000 | 418,000 |
| TOTAL | $17,095,000 | $19,803,000 | $18,100,000 | $18,031,000 | $16,103,000 |
| Non-Current Assets | |||||
| PPE Net | 6,591,000 | 6,240,000 | 6,170,000 | 6,140,000 | 6,124,000 |
| Intangibles | 13,817,000 | 14,040,000 | 14,126,000 | 14,194,000 | 14,263,000 |
| Other Non-Current Assets | 10,025,000 | 9,192,000 | 9,444,000 | 9,319,000 | 8,386,000 |
| TOTAL | $30,433,000 | $29,472,000 | $29,740,000 | $29,653,000 | $28,773,000 |
| Total Assets | $47,528,000 | $49,275,000 | $47,840,000 | $47,684,000 | $44,876,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 1,250,000 | 900,000 | 900,000 | 1,300,000 | 1,500,000 |
| Accounts payable and accrued liabilities | 1,281,000 | 2,904,000 | 2,611,000 | 3,097,000 | 2,402,000 |
| Accrued Expenses | 2,466,000 | 2,308,000 | 2,077,000 | 1,861,000 | 2,122,000 |
| Other current liabilities | 1,921,000 | 2,626,000 | 2,778,000 | 2,349,000 | 1,883,000 |
| TOTAL | $13,972,000 | $15,515,000 | $15,132,000 | $15,403,000 | $14,398,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 11,404,000 | 12,652,000 | 12,637,000 | 12,621,000 | 12,604,000 |
| Deferred Revenues | 7,054,000 | 6,777,000 | 6,766,000 | 6,796,000 | 6,491,000 |
| Other Non-Current Liabilities | 18,937,000 | 17,127,000 | 17,129,000 | 17,081,000 | 16,370,000 |
| TOTAL | $30,385,000 | $29,823,000 | $29,812,000 | $29,759,000 | $29,029,000 |
| Total Liabilities | $44,357,000 | $45,338,000 | $44,944,000 | $45,162,000 | $43,427,000 |
| Shareholders' Equity | |||||
| Common Shares | 280,000 | 281,000 | 281,000 | 281,000 | 281,000 |
| Retained earnings | 18,401,000 | 17,265,000 | 16,408,000 | 16,278,000 | 15,434,000 |
| Other shareholders' equity | -15,554,000 | -13,653,000 | -13,839,000 | -14,094,000 | -14,321,000 |
| TOTAL | $3,127,000 | $3,893,000 | $2,850,000 | $2,465,000 | $1,394,000 |
| Total Liabilities And Equity | $47,484,000 | $49,231,000 | $47,794,000 | $47,627,000 | $44,821,000 |